
Patologie trattate
- Scompenso cardiaco
- Cardiomiopatie
- Ipertensione polmonare
- Trapianto cardiaco
- Cardiopatia ischemica
- Ipertensione arteriosa
- Valvulopatie
- Aritmie atriali e ventricolari
Formazione accademica
- Laurea in Medicina e Chirurgia nel 1982, Università degli Studi Cagliari (110/110 e lode)
- Specializzazione in Cardiologia nel 1986, Università degli Studi di Sassari (50/50)
- Specializzazione in Radiologia nel 1992, Università degli Studi di Cagliari (48/50)
Comandi e aggiornamenti
- Centro Trapianti Cardiaci Papworth Hospital , Cambridge (GB)
- Laboratorio di Emodinamica Thoraxcenter, Rotterdam (OL)
- Laboratorio di Emodinamica Clinique Pasteur, Tolosa (FR)
- Centro Trapianti Cardiaci e Scompenso Refrattario Policlinico S. Matteo, Pavia
- Dipartimento di Medicina, Divisione Cardiovascolare, Centro per le Cardiomiopatie e Trapianto Cardiaco, Brigham and Women’s Hospital, Harvard Medical School, Boston, (USA)
- Dipartimento di Medicina, Divisione di Cardiologia, Northwestern University Medical School, Chicago (USA)
Posizioni ricoperte
Azienda di rilievo nazionale e alta specializzazione G. Brotzu di Cagliari:
- Direttore della SSD Coordinamento Scompenso e Trapianto Cardiaco, dal 2001 al 2004
- Direttore della Struttura Complessa di Cardiologia con UTIC, dal 2004 al luglio 2021
- Direttore del Dipartimento Cardio-Toraco-Vascolare, dal 2010 al 2017
Associazioni scientifiche
- Fellow della European Society of Cardiology
- European Heart Rhythm Association
- Heart Failure Association
- International Society of Heart and Lung Transplantation
- Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO)
Attività scientifica a pubblicazioni
- Oltre 80 pubblicazioni su riviste scientifiche, tra cui New England Journal of Medicine, Lancet, European Heart Journal, Circulation HF, European Journal of Heart Failure, American Journal of Cardiology, American Heart Journal, International Journal of Cardiology)
- Dodici capitoli di libri
- Oltre 100 abstract a congressi
- Revisore di diverse riviste a carattere internazionale
- H-index 30
Pubblicazioni
- HF) trial. Am Heart J. 2011 Feb;161(2):338-343.e1. doi:
10.1016/j.ahj.2010.10.032. PMID: 21315217. 23: Carboni N, Mura M, Marrosu G, Cocco E, Marini S, Solla E, Mateddu A, MaioliMA, Piras R, Mallarini G, Mercuro G, Porcu M, Marrosu MG. Muscle imaginganalogies in a cohort of patients with different clinical phenotypes caused byLMNA gene mutations. Muscle Nerve. 2010 Apr;41(4):458-63. doi:10.1002/mus.21514. PMID: 19882644. 24: Carboni N, Porcu M, Mura M, Cocco E, Marrosu G, Maioli MA, Solla E,Tranquilli S, Orrù P, Marrosu MG. Evolution of the phenotype in a family with anLMNA gene mutation presenting with isolated cardiac involvement. Muscle Nerve.2010 Jan;41(1):85-91. doi: 10.1002/mus.21443. PMID: 19768759. 25: Maggioni AP, Fabbri G, Lucci D, Marchioli R, Franzosi MG, Latini R, NicolosiGL, Porcu M, Cosmi F, Stefanelli S, Tognoni G, Tavazzi L; GISSI-HFInvestigators. Effects of rosuvastatin on atrial fibrillation occurrence:ancillary results of the GISSI-HF trial. Eur Heart J. 2009 Oct;30(19):2327-36.doi: 10.1093/eurheartj/ehp357. Epub 2009 Aug 30. PMID: 19717850. 26: Marchioli R, Levantesi G, Silletta MG, Barlera S, Bernardinangeli M,Carbonieri E, Cosmi F, Franzosi MG, Latini R, Lucci D, Maggioni AP, Moretti L,Nicolosi GL, Porcu M, Rossi MG, Tognoni G, Tavazzi L; GISSI-HF Investigators.Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients withheart failure: results of the GISSI-HF trial. Expert Rev Cardiovasc Ther. 2009Jul;7(7):735-48. doi: 10.1586/erc.09.70. PMID: 19589110. 27: Boccanelli A, Mureddu GF, Cacciatore G, Clemenza F, Di Lenarda A, Gavazzi A,Porcu M, Latini R, Lucci D, Maggioni AP, Masson S, Vanasia M, de Simone G; AREAIN-CHF Investigators. Anti-remodelling effect of canrenone in patients with mildchronic heart failure (AREA IN-CHF study): final results. Eur J Heart Fail. 2009Jan;11(1):68-76. doi: 10.1093/eurjhf/hfn015. PMID: 19147459. 28: Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, LucciD, Nicolosi GL, Porcu M, Tognoni G; Gissi-HF Investigators. Effect of n-3polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HFtrial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008 Oct4;372(9645):1223-30. doi: 10.1016/S0140-6736(08)61239-8. Epub 2008 Aug 29. PMID:18757090. 29: Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, LucciD, Nicolosi GL, Porcu M, Tognoni G; Gissi-HF Investigators. Effect ofrosuvastatin in patients with chronic heart failure (the GISSI-HF trial): arandomised, double-blind, placebo-controlled trial. Lancet. 2008 Oct4;372(9645):1231-9. doi: 10.1016/S0140-6736(08)61240-4. Epub 2008 Aug 29. PMID:18757089. 30: Boccanelli A, Cacciatore G, Mureddu GF, de Simone G, Clemenza F, De Maria R,Di Lenarda A, Gavazzi A, Latini R, Masson S, Porcu M, Vanasia M, Gonzini L,Maggioni AP. Baseline characteristics of patients recruited in the AREA IN-CHFstudy (Antiremodelling Effect of Aldosterone Receptors Blockade with Canrenonein Mild Chronic Heart Failure). J Cardiovasc Med (Hagerstown). 2007Sep;8(9):683-91. doi: 10.2459/JCM.0b013e3281053a9a. PMID: 17700397. 31: Porcu M, Landis N, Salis S, Corda M, Orrù P, Serra E, Usai B, Matta G,Galanello R. Effects of combined deferiprone and desferrioxamine iron chelatingtherapy in beta-thalassemia major end-stage heart failure: a case report. Eur JHeart Fail. 2007 Mar;9(3):320-2. doi: 10.1016/j.ejheart.2006.08.006. Epub 2006Oct 5. PMID: 17029959. 32: Tavazzi L, Maggioni AP, Lucci D, Cacciatore G, Ansalone G, Oliva F, Porcu M;Italian survey on Acute Heart Failure Investigators. Nationwide survey on acuteheart failure in cardiology ward services in Italy. Eur Heart J. 2006May;27(10):1207-15. doi: 10.1093/eurheartj/ehi845. Epub 2006 Apr 7. PMID:16603579. 33: Opasich C, Boccanelli A, Cafiero M, Cirrincione V, Sindaco DD, Lenarda AD,Luzio SD, Faggiano P, Frigerio M, Lucci D, Porcu M, Pulignano G, Scherillo M,Tavazzi L, Maggioni AP; BRING-UP 2 Investigators. Programme to improve the useof beta-blockers for heart failure in the elderly and in those with severesymptoms: results of the BRING-UP 2 Study. Eur J Heart Fail. 2006Oct;8(6):649-57. doi: 10.1016/j.ejheart.2005.11.005. Epub 2006 Feb 8. PMID:16466962. 34: Corda M, Orrù P, Saiu F, Giardina G, Pani A, Salis S, Porcu M. Lo scompensocardiaco diastolico: aspetti clinici, fisiopatologici e terapeutici [Diastolicheart failure]. G Ital Nefrol. 2006 Jan-Feb;23 Suppl 34:S38-43. Italian. PMID:16633993. 35: Cecchi F, Olivotto I, Betocchi S, Rapezzi C, Conte MR, Sinagra G, Zachara E,Gavazzi A, Rordorf R, Carnemolla G, Porcu M, Nistri S, Gruppillo P, Giampaoli S.The Italian Registry for hypertrophic cardiomyopathy: a nationwide survey. AmHeart J. 2005 Nov;150(5):947-54. doi: 10.1016/j.ahj.2005.01.005. PMID: 16290970. 36: Senni M, De Maria R, Gregori D, Gonzini L, Gorini M, Cacciatore G, GavazziA, Pulignano G, Porcu M, Maggioni AP. Temporal trends in survival andhospitalizations in outpatients with chronic systolic heart failure in 1995 and
- J Card Fail. 2005 May;11(4):270-8. doi: 10.1016/j.cardfail.2004.11.003.
PMID: 15880335. 37: Schillaci G, Di Luzio S, Coluccini M, Gonzini L, Porcu M, Pozzar F, MaggioniAP; Italian Network of Congestive Heart Failure Registry. A low pulse pressureis an independent predictor of mortality in heart failure: data from a largenationwide cardiology database (IN-CHF Registry). Ital Heart J. 2004Dec;5(12):892-8. PMID: 15706993. 38: Tavazzi L, Tognoni G, Franzosi MG, Latini R, Maggioni AP, Marchioli R,Nicolosi GL, Porcu M; GISSI-HF Investigators. Rationale and design of the GISSIheart failure trial: a large trial to assess the effects of n-3 polyunsaturatedfatty acids and rosuvastatin in symptomatic congestive heart failure. Eur JHeart Fail. 2004 Aug;6(5):635-41. doi: 10.1016/j.ejheart.2004.03.001. PMID:15302013. 39: Di Lenarda A, Scherillo M, Maggioni AP, Acquarone N, Ambrosio GB,Annicchiarico M, Bellis P, Bellotti P, De Maria R, Lavecchia R, Lucci D, MathieuG, Opasich C, Porcu M, Tavazzi L, Cafiero M; TEMISTOCLE Investigators. Currentpresentation and management of heart failure in cardiology and internal medicinehospital units: a tale of two worlds–the TEMISTOCLE study. Am Heart J. 2003Oct;146(4):E12. doi: 10.1016/S0002-8703(03)00315-6. PMID: 14564335. 40: Baldasseroni S, Gentile A, Gorini M, Marchionni N, Marini M, Masotti G,Porcu M, Maggioni AP; Italian Network on Congestive Heart Failure Investigators.Intraventricular conduction defects in patients with congestive heart failure:left but not right bundle branch block is an independent predictor of prognosis.A report from the Italian Network on Congestive Heart Failure (IN-CHF database).Ital Heart J. 2003 Sep;4(9):607-13. PMID: 14635378. 41: Bobbio M, Ferrua S, Opasich C, Porcu M, Lucci D, Scherillo M, Tavazzi L,Maggioni AP; BRING-UP Investigators. Survival and hospitalization in heartfailure patients with or without diabetes treated with beta-blockers. J CardFail. 2003 Jun;9(3):192-202. doi: 10.1054/jcaf.2003.31. PMID: 12815569. 42: Mangia R, Senni M, Cacciatore G, Del Sindaco D, Pozzi R, Di Lenarda A, OlivaF, Clemenza F, Porcu M. E tempo di organizzare una “nuova” lotta allo scompensocardiaco? [Is it time to organize a “new ” campaign against congestive heartfailure?]. Ital Heart J Suppl. 2003 Mar;4(3):232-6. Italian. PMID: 12784758. 43: Porcu M, Opasich C, Scherillo M, Lucci D, De Maria R, Di Tano G, MaggioniAP; Italian Network on Congestive Heart Failure (IN-CHF) Investigators.Improving practice patterns in heart failure through a national cardiologicalnetwork: the case of ACE-inhibitors. Ital Heart J. 2002 Dec;3(12):730-7. PMID:12611125. 44: Tarantini L, Faggiano P, Senni M, Lucci D, Bertoli D, Porcu M, Opasich C,Tavazzi L, Maggioni AP. Clinical features and prognosis associated with apreserved left ventricular systolic function in a large cohort of congestiveheart failure outpatients managed by cardiologists. Data from the ItalianNetwork on Congestive Heart Failure. Ital Heart J. 2002 Nov;3(11):656-64. PMID:12506524. 45: Baldasseroni S, De Biase L, Fresco C, Marchionni N, Marini M, Masotti G,Orsini G, Porcu M, Pozzar F, Scherillo M, Maggioni AP; Italian Network onCongestive Heart Failure. Cumulative effect of complete left bundle-branch blockand chronic atrial fibrillation on 1-year mortality and hospitalization inpatients with congestive heart failure. A report from the Italian network oncongestive heart failure (in-CHF database). Eur Heart J. 2002 Nov;23(21):1692-8.doi: 10.1053/euhj.2001.3157. PMID: 12398827. 46: Porcu M, Cacciatore G. Strategie di intervento nello scompenso cardiacorefrattario [Intervention strategies in refractory heart failure]. Ital Heart JSuppl. 2002 Aug;3(8):791-2. Italian. PMID: 12407833. 47: Porcu M. The pharmacological treatment of heart failure: are we looking atthe sunset of the neurohormonal hypothesis. Ital Heart J. 2002 Jul;3(7):437-8.PMID: 12189976. 48: Del Sindaco D, Pulignano G, Porcu M, Scherillo M, Leggio F, Maggioni AP. Ilpaziente anziano con scompenso cardiaco nelle strutture cardiologicheospedaliere [The elderly patient with heart failure at hospital cardiologyunits]. Ital Heart J Suppl. 2002 Feb;3(2):145-53. Italian. PMID: 11926020. 49: Pulignano G, Del Sindaco D, Tavazzi L, Lucci D, Gorini M, Leggio F, Porcu M,Scherillo M, Opasich C, Di Lenarda A, Senni M, Maggioni AP; IN-CHFInvestigators. Clinical features and outcomes of elderly outpatients with heartfailure followed up in hospital cardiology units: data from a large nationwidecardiology database (IN-CHF Registry). Am Heart J. 2002 Jan;143(1):45-55. doi:10.1067/mhj.2002.119608. PMID: 11773911. 50: De Maria R, Di Lenarda A, Gavazzi A, Porcu M, Sinagra G, Parolini M; SPIC(Italian Multicenter Cardiomyopathy Study) Group. Metoprolol-induced functionalbenefit in dilated cardiomyopathy is sustained over four years and favorablyinfluences outcome. Ital Heart J. 2001 Feb;2(2):130-8. PMID: 11256541. 51: Porcu M, Orrù P. Effetti acuti emodinamici e clinici di un nuovo inotropo,il levosimendan, in pazienti con scompenso cardiaco avanzato [Acute hemodynamicand clinical effects of a new inotropic agent, levosimendan, in patients withsevere heart failure]. Ital Heart J Suppl. 2001 Feb;2(2):205-6. Italian. PMID:11255888. 52: Porcu M, Orrù P. Il ruolo attuale degli antagonisti dell’angiotensina II neltrattamento dello scompenso cardiaco [Current role of angiotensin II antagonistsin the treatment of heart failure]. Ital Heart J Suppl. 2000 Sep;1(9):1213-4.Italian. PMID: 11140296. 53: Gavazzi A, De Maria R, Parolini M, Porcu M. Alcohol abuse and dilatedcardiomyopathy in men. Am J Cardiol. 2000 May 1;85(9):1114-8. doi:10.1016/s0002-9149(00)00706-2. PMID: 10781762. 54: Fatkin D, MacRae C, Sasaki T, Wolff MR, Porcu M, Frenneaux M, Atherton J,Vidaillet HJ Jr, Spudich S, De Girolami U, Seidman JG, Seidman C, Muntoni F,Müehle G, Johnson W, McDonough B. Missense mutations in the rod domain of thelamin A/C gene as causes of dilated cardiomyopathy and conduction-systemdisease. N Engl J Med. 1999 Dec 2;341(23):1715-24. doi:10.1056/NEJM199912023412302. PMID: 10580070. 55: Muntoni F, Ferlini A, Sewry C, Mateddu A, Marrosu G, Porcu M, Di Lenarda A,Sinagra G, Mestroni L. Dilated cardiomyopathy and muscular dystrophies: whichlesson can be learned? Cardiologia. 1999 Dec;44 Suppl 1(Pt 1):209-11. PMID:12497909. 56: Muntoni F, Di Lenarda A, Porcu M, Sinagra G, Mateddu A, Marrosu G, FerliniA, Cau M, Milasin J, Melis MA, Marrosu MG, Cianchetti C, Sanna A, Falaschi A,Camerini F, Giacca M, Mestroni L. Dystrophin gene abnormalities in two patientswith idiopathic dilated cardiomyopathy. Heart. 1997 Dec;78(6):608-12. doi:10.1136/hrt.78.6.608. PMID: 9470882; PMCID: PMC1892323. 57: Gavazzi A, De Maria R, Porcu M, Beretta L, Casazza F, Castelli G, Luvini M,Parodi O, Recalcati F, Renosto G, et al. Cardiomiopatia dilatativa: una nuovastoria naturale? L’esperienza dello Studio Policentrico Italiano Cardiomiopatie(SPIC) [Dilated cardiomyopathy: a new natural history? The experience of theItalian Multicenter Cardiomyopathy Study (SPIC)]. G Ital Cardiol. 1995Sep;25(9):1109-25. Italian. PMID: 8529848. 58: Porcu M, Muntoni F, Catani G, Mereu D. Familial cardiac and skeletalmyopathy associated with desmin accumulation. Clin Cardiol. 1994May;17(5):277-9. doi: 10.1002/clc.4960170512. PMID: 8004844. 59: Muntoni F, Catani G, Mateddu A, Rimoldi M, Congiu T, Faa G, Marrosu MG,Cianchetti C, Porcu M. Familial cardiomyopathy, mental retardation and myopathyassociated with desmin-type intermediate filaments. Neuromuscul Disord. 1994May;4(3):233-41. doi: 10.1016/0960-8966(94)90024-8. PMID: 7919971. 60: Tumbarello R, Abbruzzese PA, Meloni G, Porcu M, Martelli V, Sanna A. Avariant of the scimitar syndrome with stenosed drainage of the inferior venacava. Am Heart J. 1991 Feb;121(2 Pt 1):616-8. doi: 10.1016/0002-8703(91)90742-z.PMID: 1990776. 61: Porcu M. Il Programma Nazionale di Trapianto Cardiaco [letter] [The NationalHeart Transplant Program]. G Ital Cardiol. 1990 Oct;20(10):981-2. Italian. PMID:2090540. 62: Porcu M, Meloni GF, Loi B, Tumbarello R, Cadeddu M, Lai G, Sanna A.Dissezione delle arterie coronarie secondaria ad angiografia coronaricaselettiva [Coronary artery dissection secondary to selective coronaryangiography]. Radiol Med. 1990 Mar;79(3):175-7. Italian. PMID: 2336478. 63: Sanna A, Porcu M, Basciu M, Floris E, Martelli V. Left atrial myxomasimulating a systemic disease with pleural-pericardial effusion. Detection bytwo-dimensional echocardiography. Ann Ital Med Int. 1989 Jan-Mar;4(1):44-7.PMID: 2702017. 64: Porcu M, Meloni G, Farci G, Loi B. Localizzazione idatidea nel trattoprossimale del ramo destro dell’arteria polmonare. Descrizione di un caso[Hydatid localization in the proximal tract of the right branch of the pulmonaryartery. Description of a case]. G Ital Cardiol. 1988 May;18(5):398-9. Italian.PMID: 3192046. 65: Sanna A, Martelli V, Meloni GF, Crabu E, Porcu M, Basciu M, Mereu D.Inadeguatezza dei parametri ecocardiografici M-mode nella valutazione del gradodi stenosi mitralica. Confronto con i dati intraoperatori [Inadequacy of M-modeechocardiographic parameters in evaluating the degree of mitral stenosis.Comparison with intraoperative findings]. Minerva Cardioangiol. 1987Mar;35(3):123-31. Italian. PMID: 3587663.
Consulta le pubblicazioni di maurizio porcu Vai